top of page

Videnskabelige studier om mRNA

Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries, population based cohort study

Myocarditis & Myopericarditis

Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis

Myocarditis & Myopericarditis

Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents

Myocarditis & Myopericarditis

Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination

Myocarditis & Myopericarditis

Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis

Myocarditis & Myopericarditis

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Myocarditis & Myopericarditis

Assessment of Myocardial 18F-FDG Uptake at PETCT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients.pdf

Myocarditis & Myopericarditis

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

Myocarditis & Myopericarditis

Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand

Myocarditis & Myopericarditis

Adverse Events Following SARS-CoV-2.

Myocarditis & Myopericarditis

Adjuvants in COVID-19 vaccines innocent bystanders or culpable abettors for stirring up COVID-heart syndrome

Myocarditis & Myopericarditis

Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination

Myocarditis & Myopericarditis

Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection

Myocarditis & Myopericarditis

Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19

Myocarditis & Myopericarditis

A Study on the Self-Reported PhysicianDiagnosed Cardiac Complications Post mRNA

Myocarditis & Myopericarditis

A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons

Myocarditis & Myopericarditis

Strategies for the Management of Spike Protein-Related Pathology

Long COVID versus Long Vax

Post-Vaccination Syndrome, A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization

Long COVID versus Long Vax

Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequela

Long COVID versus Long Vax

Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms

Long COVID versus Long Vax
bottom of page